Rising Dragon Acquisition Corp (RDAC) Technical Analysis: Support, Resistance, Indicators & Moving Averages
This article provides a technical analysis of Rising Dragon Acquisition Corp (RDAC), detailing its current stock price, market capitalization, and various technical indicators. It presents a summary of buy, sell, and neutral signals from indicators such as MACD, RSI, and moving averages. The analysis concludes with a "Neutral" signal based on these metrics.
Short Interest in Permianville Royalty Trust (NYSE:PVL) Expands By 158.6%
Short interest in Permianville Royalty Trust (NYSE:PVL) increased by 158.6% to 17,928 shares as of July 15th, though this still represents only about 0.1% of outstanding shares. Despite this, PVL shares remained flat at $1.70, near their 52-week low. The trust recently announced a monthly dividend of $0.015, resulting in an annualized yield of approximately 10.6%, and posted strong quarterly earnings that beat analyst estimates.
AEP Looks 19.7% Overvalued on GF Value™ Amid Heatwave Grid Stres
American Electric Power Co Inc (AEP) is currently facing challenges with its valuation, showing a 19.7% overvaluation based on the GF Value™ intrinsic estimate, with a current price of $133.59 against an estimated true value of $111.62. This overvaluation comes amidst a severe heatwave causing grid stress and an emergency order from the U.S. Department of Energy to deploy backup power. Despite high profitability and growth scores, AEP's financial strength is weak, marked by high debt and a distressed Altman Z-Score, while investor activity shows cautious optimism from gurus but insider selling.
Evergy, Inc. Revenue Breakdown – BX:EVRG
This article provides a revenue breakdown for Evergy, Inc. (BX:EVRG), detailing its top-performing sectors and geographical contributions. In the last year, the company generated CHF 4.73 billion, with the Residential segment being the largest contributor at CHF 1.74 billion, and the United States accounting for the entirety of its revenue.
NVE Corp (NVEC) Cash Flow
This article provides a detailed quarterly and annual cash flow statement for NVE Corp (NVEC), covering operating, investing, and financing activities. It presents historical financial data to assess NVE Corp's financial health, along with key performance indicators like operating cash flow, capital expenditures, and free cash flow. The article also includes a FAQ section defining these financial metrics and their significance for investors.
Oxford Square Capital Will Offer 30-Day Call Replay
Oxford Square Capital Corp. (OXSQ) has scheduled its second quarter 2026 earnings conference call for Friday, July 31, 2026, at 9:00 AM Eastern time. Investors can participate via a toll-free dial-in number, and a recorded replay of the call will be available for 30 days afterward. The article also notes recent insider net buying activity for OXSQ stock.
Preformed Line Products Co (PLPC) Earnings Forecast: Future EPS & Revenue Growth Estimates
This article provides an earnings forecast for Preformed Line Products Co (PLPC), highlighting its current earnings forecast score of 6.00 within the Machinery, Tools, Heavy Vehicles, Trains & Ships industry. It details an average price target of $221.00 based on one analyst rating of "Hold." The report also includes expected revenue for the next quarter, stock performance, and a comparison with peers.
Picard Medical / SynCardia to Present Next-Generation Emperor Total Artificial Heart Technology at IEEE EMBC 2026
Picard Medical, parent company of SynCardia Systems, will present new engineering insights into its next-generation Emperor Total Artificial Heart (Emperor TAH) system at the IEEE EMBC 2026 conference. This presentation will be the first public scientific introduction of the Emperor Drive System architecture, combining SynCardia's proven ventricles with Picard Medical's electromechanical drive system. The event highlights the company's commitment to advancing mechanical circulatory support through innovation and collaboration.
Johnson & Johnson offers to pay $5.5bn to settle baby powder lawsuits
Johnson & Johnson has offered to pay up to $5.5 billion to resolve tens of thousands of lawsuits alleging that its talc-based baby powder causes ovarian cancer. The company denies the allegations, stating that talc is safe and does not cause cancer, and asserts that it would have ultimately prevailed in court. J&J previously announced in 2022 that it would transition to an all cornstarch-based baby powder portfolio globally.
Boston Scientific to restructure, cut costs by $500M annually
Boston Scientific Corp. is implementing a new 2026 Restructuring Plan to address challenges with key revenue drivers. This initiative is expected to lead to layoffs and aims to cut annual costs by $500 million. The company is responding to difficulties in its major financial areas.

